![Brian Harvey](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Brian Harvey
Directeur Financier/CFO chez ADICET BIO, INC.
Fortune : 81 345 $ au 31/05/2024
Profil
Brian Nicholas Harvey's current job is as the Chief Financial & Accounting Officer at Adicet Bio, Inc. Mr. Harvey's former jobs include being the CFO, Secretary, Treasurer & Director at MPM Acquisition Corp.
from 2010 to 2011, Managing Director at Shiprock Capital LLC from 2003 to 2006, Director at Passport Systems, Inc., Chief Financial Officer at Transcend Therapeutics, Inc. from 1993 to 1999, CFO, Secretary, Treasurer & Senior Vice President at Radius Health, Inc. from 2006 to 2017, Chief Financial Officer, Treasurer & Executive VP at Centrexion Therapeutics Corp.
from 2018 to 2019, Chief Financial Officer at Transfusion Technologies Corp.
from 1999 to 2000, and Chief Financial Officer at Lifetecnet in 2001.
Mr. Harvey's education includes an undergraduate and graduate degree from The Australian National University and an MBA from Harvard Business School, which was conferred in 1991.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
ADICET BIO INC
0,07% | 05/06/2024 | 56 100 ( 0,07% ) | 81 345 $ | 31/05/2024 |
Postes actifs de Brian Harvey
Sociétés | Poste | Début |
---|---|---|
ADICET BIO, INC. | Directeur Financier/CFO | 01/09/2020 |
Anciens postes connus de Brian Harvey
Sociétés | Poste | Fin |
---|---|---|
CENTREXION THERAPEUTICS CORPORATION | Directeur Financier/CFO | 01/12/2019 |
RADIUS HEALTH, INC. | Directeur Financier/CFO | 15/05/2017 |
MPM Acquisition Corp.
![]() MPM Acquisition Corp. Financial ConglomeratesFinance MPM Acquisition Corp. was incorporated in the State of Delaware on February 4, 2008. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The company was formed as a vehicle to pursue a business combination. As such, the business purpose of the company is to seek the acquisition or merger with, an existing company. The company is headquartered in Boston, MA. | Directeur Financier/CFO | 24/05/2011 |
Shiprock Capital LLC
![]() Shiprock Capital LLC Investment ManagersFinance Shiprock Capital LLC (Shiprock Capital) is a venture capital firm founded in 1999 by Richard C. Shipley. The firm is headquartered in Wellesley, MA. | Private Equity Investor | 31/12/2006 |
Lifetecnet | Directeur Financier/CFO | 01/01/2002 |
Formation de Brian Harvey
Australian National University | Graduate Degree |
Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ADICET BIO, INC. | Health Technology |
Entreprise privées | 8 |
---|---|
Radius Health, Inc.
![]() Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Shiprock Capital LLC
![]() Shiprock Capital LLC Investment ManagersFinance Shiprock Capital LLC (Shiprock Capital) is a venture capital firm founded in 1999 by Richard C. Shipley. The firm is headquartered in Wellesley, MA. | Finance |
Passport Systems, Inc.
![]() Passport Systems, Inc. Industrial MachineryProducer Manufacturing Passport Systems, Inc. provides scanning system services. It develops active and passive solutions to automatically detect, localize, and identify concealed threats and contraband for a broad range of applications, including pedestrian, vehicle, and fixed-facility-based approaches. The firm offers an automated, non-intrusive Cargo Scanning System that has the capability to analyze the composition of materials and accurately identify the contents of a container, including commercial items, contraband, fissile materials, explosives, and other materials. The company was founded by William Bertozzi, Robert J. Ledoux and Stewart K. Hall in December 2002 and is headquartered in Billerica, MA. | Producer Manufacturing |
MPM Acquisition Corp.
![]() MPM Acquisition Corp. Financial ConglomeratesFinance MPM Acquisition Corp. was incorporated in the State of Delaware on February 4, 2008. Since inception, the company has been engaged in organizational efforts and obtaining initial financing. The company was formed as a vehicle to pursue a business combination. As such, the business purpose of the company is to seek the acquisition or merger with, an existing company. The company is headquartered in Boston, MA. | Finance |
Transfusion Technologies Corp.
![]() Transfusion Technologies Corp. Medical SpecialtiesHealth Technology Natick-based Transfusion Technologies Corp., is a private company that specializes in blood separation systems. It manufactures medical devices. | Health Technology |
Transcend Therapeutics, Inc.
![]() Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transcend Therapeutics, Inc. develops and markets pharmaceutical products. It offers its products for oxidative stress, cytokine dysfunction, and multiple organ dysfunctions. The company was founded by Dennis I. Goldberg and Gary W. Pace in 1992 and is headquartered in Cambridge, MA. | Health Technology |
Lifetecnet | |
Centrexion Therapeutics Corp.
![]() Centrexion Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Centrexion Therapeutics Corp. is a clinical-stage biopharmaceutical company, which engages in identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the large unmet medical need for the treatment of chronic pain. Its product pipeline includes CNTX-4975, CNTX-0290, CNTX-6970, CNTX-2022, CNTX-6016, and intrathecal platform. The company was founded by Sol J. Barer and Jeffrey B. Kindler in February 2013 and is headquartered in Boston, MA. | Health Technology |